Login / Signup

Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis.

Johannes LorscheiderPascal BenkertCarmen LienertPeter HänniTobias DerfussJens KuhleLudwig KapposÖzgür Yaldizli
Published in: Journal of neurology (2020)
Dimethyl fumarate and fingolimod have comparable effectiveness regarding reduction of relapses and disability worsening in RRMS.
Keyphrases
  • multiple sclerosis
  • white matter
  • randomized controlled trial
  • systematic review
  • rheumatoid arthritis